Latest Thrombus Stories

An experimental device for removing blood clots in stroke patients dramatically outperformed the standard mechanical treatment, according to research presented by UCLA Stroke Center director Dr. Jeffrey L. Saver at the American Stroke Association's 2012 international conference in New Orleans on Feb. 3. The SOLITAIRE Flow Restoration Device is among an entirely new generation of devices designed to remove blood clots from blocked brain arteries in patients experiencing stroke. It has a...

An experimental blood clot-removing device outperformed the FDA-approved MERCI; retriever device, according to late-breaking science presented at the American Stroke Association’s 2012 International Stroke Conference. The SOLITAIRE; Flow Restoration Device is a self-expanding stent-based design that mechanically removes blood clots from blocked vessels after a stroke. After insertion into the clot using a thin tube, or catheter, the device traps the clot then both device and clot are...

CT-guided catheters carry clot-busting drug to shrink clots, Johns Hopkins-led study shows Johns Hopkins neurologists report success with a new means of getting rid of potentially lethal blood clots in the brain safely without cutting through easily damaged brain tissue or removing large pieces of skull. The minimally invasive treatment, they report, increased the number of patients with intracerebral hemorrhage (ICH) who could function independently by 10 to 15 percent six months...

The US Drug Watchdog is expanding its national investigation of the birth control drugs called Yaz and Yasmin given increasing evidence these drugs may be responsible for serious pulmonary embolism's, deep vein thrombosis, heart attacks, strokes and other serious side affects with users. According to the New York Times, "In September of 2009, the Food and Drug Administration (FDA) cited Bayer for running misleading television commercials, and for not following proper...

The US Drug Watchdog is calling its Yaz, Yasmin, or the generic version of these birth control pills called Ocella, their most important women's health care initiative ever. The group says, "If a user of the birth control pills called Yaz, Yasmin, or the generic version Ocella has had a pulmonary embolism, a heart attack, stroke, blood clotting, or other severe medical complications, while taking these birth control pills, we want to know about it. We are hearing horror stories...

NEWBURY, England, December 19, 2011 /PRNewswire/ -- - First once-daily, fixed-dose preventative treatment for UK patients with non-valvular atrial fibrillation (an irregular heartbeat) at risk of the devastating consequences of stroke - Xarelto offers a convenient, cost-effective, single drug solution for the treatment of deep vein thrombosis (DVT) without the need for regular injections - Xarelto is now approved in...

People with low levels of iron in the blood have a higher risk of dangerous blood clots, according to research published in the journal Thorax today. A study of clotting risk factors in patients with an inherited blood vessel disease suggests that treating iron deficiency might be important for preventing potentially lethal blood clots. Each year, one in every 1,000 people in the UK is affected by deep vein thrombosis – blood clots that form in the veins. These can cause pain and...

(Ivanhoe Newswire) – Blood clots are a well-known and serious complication of cancer treatment, and according to a study, 78 percent of the time they occur when a person is out of the hospital. This data is striking because, until now, outpatients had not been systematically studied and previous data gathered on the incidence of blood clots was mostly from hospitalized patients, who tend to be sicker. However, with a shift toward outpatient cancer treatment, future efforts to prevent...

In a study of nearly 18,000 cancer patients, University of Rochester Medical Center researchers found that when blood clots develop – a well-known and serious complication of cancer treatment – 78 percent of the time they occur when a person is out of the hospital, at home or elsewhere, while on chemotherapy. This data is striking because, until now, outpatients had not been systematically studied and previous data gathered on the incidence of blood clots was mostly from hospitalized...

DENVER, Dec. 8, 2011 /PRNewswire-USNewswire/ -- Deep vein thrombosis (DVT) is a blood clot in the deep veins in the legs. These clots can break loose and travel to the lungs, causing a potentially fatal pulmonary embolism (PE). Even when they don't, they can cause permanent damage to the leg veins that results in long-term pain, swelling, and disability of the leg. (Logo: <font size="2" face="Arial">http://photos.prnewswire.com/prnh/20110303/DC58830LOGO</font>) Deep...